Clinical trial
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
NCT00000319 · Yale University, Other · Completed
Key facts
| NCT number | NCT00000319 |
|---|---|
| Title | Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2 |
| Official title | Buprenorphine Maintenance Dose Schedule and Treatment Setting |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders, Substance-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine |
| Enrollment | 0 |
| Start date | Jun 1, 1996 |
| Completion | Jan 1, 2005 |
| First posted | Sep 21, 1999 |
| Last update posted | Jul 7, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: